全文获取类型
收费全文 | 2345篇 |
免费 | 101篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 20篇 |
妇产科学 | 4篇 |
基础医学 | 87篇 |
口腔科学 | 20篇 |
临床医学 | 121篇 |
内科学 | 93篇 |
皮肤病学 | 8篇 |
神经病学 | 9篇 |
特种医学 | 12篇 |
外科学 | 50篇 |
综合类 | 272篇 |
预防医学 | 234篇 |
眼科学 | 3篇 |
药学 | 1441篇 |
2篇 | |
中国医学 | 73篇 |
肿瘤学 | 14篇 |
出版年
2024年 | 3篇 |
2023年 | 52篇 |
2022年 | 94篇 |
2021年 | 104篇 |
2020年 | 98篇 |
2019年 | 176篇 |
2018年 | 140篇 |
2017年 | 69篇 |
2016年 | 34篇 |
2015年 | 55篇 |
2014年 | 209篇 |
2013年 | 162篇 |
2012年 | 175篇 |
2011年 | 184篇 |
2010年 | 138篇 |
2009年 | 101篇 |
2008年 | 88篇 |
2007年 | 93篇 |
2006年 | 81篇 |
2005年 | 61篇 |
2004年 | 27篇 |
2003年 | 22篇 |
2002年 | 14篇 |
2001年 | 14篇 |
2000年 | 13篇 |
1999年 | 16篇 |
1998年 | 12篇 |
1997年 | 2篇 |
1996年 | 9篇 |
1995年 | 6篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1988年 | 1篇 |
1985年 | 22篇 |
1984年 | 78篇 |
1983年 | 16篇 |
1982年 | 21篇 |
1981年 | 23篇 |
1980年 | 15篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 5篇 |
1974年 | 2篇 |
排序方式: 共有2464条查询结果,搜索用时 31 毫秒
1.
2.
3.
《Research in social & administrative pharmacy》2020,16(11):1597-1601
Disseminating research findings from global health collaborations is essential to advancing science. However, there are a number of ethical considerations and potential challenges to address to ensure thoughtful and non-exploitative reporting. The factors include the benefits and risks to publication, authorship criteria or values, and the accessibility of forums or journals in which to pursue publication. This paper provides commentary related to planning for writing, communicating intentions to publish, obtaining permissions to publish, risks in internationally collaborative work, authorship principles, and journal selection. Authors' and editors’ knowledge of experienced individuals from both pharmacy literature, medical fields, and general publications is incorporated to provide an assessment of risks and benefits of publication of international global health research. 相似文献
4.
5.
Jeroen M. van de Pol Jurjen G. Geljon Svetlana V. Belitser Geert W.J. Frederix Anke M. Hövels Marcel L. Bouvy 《Research in social & administrative pharmacy》2019,15(1):70-76
Introduction
The nature of community pharmacy is changing, shifting from the preparation and distribution of medicines to the provision of cognitive pharmaceutical services (CPS); however, often the provision of traditional services leaves little time for innovative services. This study investigated the time community pharmacists spend on the tasks and activities of daily practice and to what extent they are able to implement CPS-related services in daily practice.Methods
Self-reporting work sampling was used to register the activities of community pharmacists. A smartphone application, designed specifically for this purpose, alerted participants to register their current activity five times per working day for 6 weeks. Participants also completed an online survey about baseline characteristics.Results
Ninety-one Dutch community pharmacists provided work-sampling data (7848 registered activities). Overall, 51.5% of their time was spent on professional activities, 35.4% on semi-professional activities, and 13.1% on non-professional activities. The proportion of time devoted to CPS decreased during the workweek, whereas the time spent on traditional task increased.Discussion and conclusion
This study shows it is feasible to collect work-sampling data using smartphone technology. Community pharmacists spent almost half of their time on semi-professional and non-professional activities, activities that could be delegated to other staff members. In practice, the transition to CPS is hampered by competing traditional tasks, which prevents community pharmacists from profiling themselves as pharmaceutical experts in daily practice. 相似文献6.
7.
Thane Lawrie Catriona Matheson Christine Bond Kay Roberts 《The International journal on drug policy》2003,14(5-6):445
Community pharmacists contribution to the management of drug problems is considerable. As the use of illicit drugs has increased, pharmacists have come under increasing pressure to offer services to problem drug users. However, there is concern among some pharmacists that offering such services may deter other customers. There is particular concern among some pharmacists about needle exchange services. Only 9.5% of Scottish pharmacies offer needle exchange services compared to 69% which are dispensing methadone (57% of which supervise methadone consumption). Qualitative interviews were used in a purposive sample of 10 pharmacies in Scotland. Eight customers were interviewed in each pharmacy to ascertain pharmacy customers’ views on these services. The majority of customers were supportive of these services. Customers were often unaware that the pharmacy they were interviewed in was offering services for people with drug problems. Pharmacy customers were more knowledgeable about, and more supportive, of needle exchange services than they were of methadone. This was because they believed needle exchange services helped to reduce the amount of discarded needles in public places. Pharmacy customers also recognised that needle exchange helped reduce the spread of disease. These findings should be used to encourage more pharmacists to offer needle exchange services. 相似文献
8.
新安药店始于宋,成于明,至清末一度达到鼎盛。较有代表的宋有“陆氏保和堂”,明有“徐保元堂”、“正田药店”、“胞与堂”等,清有“胡庆余堂”、“胡咸春”、“种德堂”等。这些药店明多为医家兼营,清多为徽商经营。新安药店作为集医疗、生产、经营一体的传统手工业,至今不少成为著名药厂,如“武汉健民制药厂”、“胡庆余堂”等。其在生产、经营、管理上积累了许多经验,同时在方剂学以及药物炮炙、贮藏、采集、加工、成方制作等方面皆有不少成就。 相似文献
9.
10.
Almost every national and supranational health policy document accords high importance to the need to listen to and ‘empower’
patients. The relationship between pharmaceutical policy and the lay public is not direct but mediated by several actors,
including health care workers, patient organisations, industry and, most recently, the media. Although the overall aim of
health and pharmaceutical policy is to address the needs of all citizens, there are only a few, well organised groups who
are actually consulted and involved in the policymaking process, often with the support of the industry. The reasons for this
lack of citizen involvement in health and pharmaceutical policymaking are many, for example: there is no consensus about what
public involvement means; there is a predominance of special interest groups with narrow, specific agendas; not all decision
makers welcome lay participation; patients and professionals have different rationalities with regard to their views on medicine.
Because the lay public and medicine users are not one entity, one of the many challenges facing policy makers today is to
identify, incorporate and prioritise the many diverse needs. The authors recommend research which includes studies that look
at: lay attitudes towards pharmaceutical policy; lay experiences of drug therapy and how it affects their daily lives; the
problem of identifying lay representatives; the relationship between industry and the consumers; the effect of the media on
medicine users and on pharmaceutical policy itself. The authors acknowledge that although lay involvement in policy is still
in its infancy, some patient organisations have been successful and there are developments towards increased lay involvement
in pharmaceutical policymaking.
This article is the fourth in a series of articles on this topic that will appear in Pharmacy World & Science during 2005. 相似文献